HYSCX | PHYEX | HYSCX / PHYEX | |
Total Expense Ratio | 1.75 | 0.91 | 192% |
Annual Report Gross Expense Ratio | 1.81 | 0.94 | 193% |
Fund Existence | 13 years | 8 years | - |
Gain YTD | 4.841 | 5.833 | 83% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 5.03B | 20.5B | 25% |
Annual Yield % from dividends | 5.63 | 6.81 | 83% |
Returns for 1 year | 7.36 | 9.37 | 79% |
Returns for 3 years | 19.66 | 22.22 | 88% |
Returns for 5 years | 25.01 | 24.32 | 103% |
Returns for 10 years | 49.73 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
OCTT | 41.35 | 0.33 | +0.81% |
AllianzIM US Large Cap Buffer10 Oct ETF | |||
ETW | 8.94 | 0.02 | +0.22% |
Eaton Vance Tax-Managed Global Buy-Write Opportunities Fund | |||
BNY | 9.66 | 0.02 | +0.21% |
BlackRock New York Municipal Income Trust | |||
XDAT | 26.20 | N/A | N/A |
Franklin Exponential Data ETF | |||
THNR | 22.00 | N/A | N/A |
Amplify Weight Loss Drug & Treatment ETF |